Nurse Practitioner, Family · New York, NY
NPI
1376010322
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
622 West 168th Street, Ph12, Room 1270
New York, NY, 10032
Phone (212) 317-6758
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$30.2M
3,224 prescriptions
Company payments, 2025
$5,812
From 10 companies
Medicare prescription drug claims, 2024
In 2024, the drug Margaret O Cuomo prescribed most often to Medicare patients was Vyndamax (Tafamidis), with 892 prescriptions and refills. In total Margaret O Cuomo wrote 3,224 Medicare prescriptions that cost $30.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-10-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Vyndamax Tafamidis | 892 | 1,257 | 137 | $27.2M |
| Eliquis Apixaban | 236 | 542 | 73 | $312K |
| Spironolactone Generic | 232 | 606 | 82 | $2,157 |
| Torsemide Generic | 153 | 391 | 54 | $3,788 |
| Farxiga Dapagliflozin Propanediol | 148 | 361 | 43 | $200K |
| Jardiance Empagliflozin | 142 | 381 | 50 | $219K |
| Atorvastatin Calcium Generic | 110 | 300 | 45 | $1,181 |
| Eplerenone Generic | 105 | 311 | 36 | $8,406 |
| Furosemide Generic | 98 | 278 | 36 | $703 |
| Entresto Sacubitril/Valsartan | 95 | 232 | 38 | $152K |
| Metoprolol Succinate Generic | 95 | 269 | 37 | $1,953 |
| Carvedilol Generic | 84 | 228 | 28 | $648 |
| Allopurinol Generic | 62 | 186 | 22 | $665 |
| Amlodipine Besylate Generic | 58 | 148 | 21 | $333 |
| Losartan Potassium Generic | 45 | 104 | 14 | $279 |
Brand drugs: 1,726 claims; generic drugs: 1,498 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Margaret O Cuomo $5,812 ($5,812 in general payments such as food, travel and fees) from 10 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $4,160.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 13 | $4,160 |
| BridgeBio Pharma, Inc. BBIO | 3 | $985 |
| Novartis Pharmaceuticals Corporation NVS | 23 | $347 |
| Alnylam Pharmaceuticals Inc. ALNY | 3 | $82.17 |
| Abbott Laboratories ABT | 1 | $75 |
| CVRx, Inc. CVRX | 2 | $55.26 |
| Kestra Medical Technology Services, Inc. | 1 | $52.82 |
| Scpharmaceuticals Inc. SCPH | 1 | $21.12 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $18.52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.